BioSenic S.A. (ENXTBR: BIOS)
Health Care · Biotechnology · BE
€0.00
-9.09% today · -16.7% 1Y
BioSenic S.A. (ENXTBR: BIOS) operates in the Biotechnology industry within the Health Care sector. The company is valued at $1.47M and employs 12 people.
Over the last twelve months the share price has lost 16.7%, trading between 0.00 and 0.00.
Tweenvest scores BioSenic S.A. across four factors: quality 23/100, value 28/100. Its strongest factor is value.
BIOS price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.47M
- Revenue (TTM)
- $-3.04M
- P/E
- —
- EPS
- -0.01
- Dividend yield
- —
- Beta (5Y)
- -1.58
- 52-week high
- €0.00
- 52-week low
- €0.00
- Avg volume (3M)
- —
- Shares outstanding
- 652.86M
- Employees
- 12
- Next earnings
- —
About BioSenic S.A.
BioSenic S.A., a biotechnology company located in Mont-Saint-Guibert, Belgium, is dedicated to progressing clinical therapeutic solutions. The firm utilizes two primary technology platforms: an innovative allogeneic cell and gene therapy system featuring distinct bone marrow-derived mesenchymal stromal cells designed for convenient on-site hospital storage; and an Arsenic Trioxide platform. The latter is deployed in immuno-oncology to target illnesses such as graft-versus-host disease, systemic lupus erythematosus, and systemic sclerosis. The company's leading experimental drug, ALLOB, is currently undergoing a Phase IIb clinical trial for patients with complicated tibial fractures.
- ISIN
- BE0974280126
- Listed since
- Feb 3, 2015
- Exchange
- Euronext Brussels
- Currency
- EUR
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Neural Therapeutics Inc.CNSX: NURL | $1.79M | CA$0.02 | -25.00% |
| Respiratorius AB (publ)XSAT: RESP | $1.72M | Skr— | — |
| Curis, Inc.NasdaqCM: CRIS | $1.59M | $0.39 | -4.59% |
| Genprex, Inc.NasdaqCM: GNPX | $1.48M | $1.81 | -8.59% |
| Hexima LimitedASX: HXL | $1.44M | AU$— | — |
| NKGen Biotech, Inc.OTCPK: NKGN | $1.44M | $0.01 | -0.90% |
| Lakewood-Amedex Biotherapeutics, Inc.NasdaqCM: LABT | $1.37M | $0.58 | -25.85% |
| Protagenic Therapeutics, Inc.OTCPK: PTIX | $1.36M | $0.75 | -2.60% |
Figures last refreshed Oct 18, 2026.